|
Volumn 25, Issue 4, 1998, Pages 483-491
|
Current approaches to the management of non-Hodgkin's lymphoma
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMOXICILLIN;
ANTHRACYCLINE;
ASPARAGINASE;
BISMUTH SALICYLATE;
BLEOMYCIN;
CHLORAMBUCIL;
CISPLATIN;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DEXAMETHASONE;
DOXORUBICIN;
ETOPOSIDE;
FLUDARABINE;
FOLINIC ACID;
IFOSFAMIDE;
INTERFERON;
METHOTREXATE;
METRONIDAZOLE;
MITOXANTRONE;
OMEPRAZOLE;
PREDNISOLONE;
VINCRISTINE;
B CELL LYMPHOMA;
CANCER COMBINATION CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CANCER RECURRENCE;
CANCER REGRESSION;
CANCER STAGING;
CANCER SURVIVAL;
CLINICAL TRIAL;
DOSE RESPONSE;
FOLLICULAR LYMPHOMA;
GRAM NEGATIVE INFECTION;
HUMAN;
IMMUNOPHENOTYPING;
MANTLE CELL LYMPHOMA;
MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA;
NONHODGKIN LYMPHOMA;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
REVIEW;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
HUMANS;
LYMPHOMA, B-CELL;
LYMPHOMA, DIFFUSE;
LYMPHOMA, FOLLICULAR;
LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TISSUE;
LYMPHOMA, NON-HODGKIN;
LYMPHOMA, SMALL CLEAVED-CELL, DIFFUSE;
|
EID: 0031928918
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (76)
|
References (55)
|